A bioconjugated MoS2 based nanoplatform with increased binding efficiency to cancer cells.
Biomater Sci
; 8(7): 1973-1980, 2020 Mar 31.
Article
in En
| MEDLINE
| ID: mdl-32065173
ABSTRACT
We evaluate the application of surfactant-free liquid-phase exfoliated MoS2 nanosheets as a nanoplatform for a cancer detection and treatment system equipped with an antibody-antigen based recognition element. Employing antigen-antibody binding, we increased the probability of the endocytosis of MoS2 nanosheets into CAIX expressing cells by 30%. The nanosheets are functionalized with a specific antibody M75, which forms an antigen-antibody complex with CAIX. The bioconjugation of MoS2 nanosheets involves biocompatible components with low cytotoxicity, verified in the tested cell lines by fluorescence-based cell viability assay. The cellular internalization is quantified by flow cytometry, while the internalization is confirmed by label-free confocal Raman imaging. Raman measurements show increased lysosomal activity in the proximity of the internalized nanoplatforms.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Disulfides
/
Carbonic Anhydrase IX
/
Molybdenum
/
Antibodies, Monoclonal
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Biomater Sci
Year:
2020
Document type:
Article
Affiliation country:
Slovakia
Country of publication:
ENGLAND
/
ESCOCIA
/
GB
/
GREAT BRITAIN
/
INGLATERRA
/
REINO UNIDO
/
SCOTLAND
/
UK
/
UNITED KINGDOM